)
Visual24 Oct 2025
The rise of Alphabet
Verrica Pharmaceuticals (VRCA) investor relations material
Verrica Pharmaceuticals H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H.C. Wainwright 27th Annual Global Investment Conference summary8 Sep, 2025
Business overview and recent progress
Focused on dermatology with two late-stage assets addressing unmet needs in molluscum contagiosum and common warts.
CEO rejoined about a year ago to reframe commercial strategy and pipeline execution.
Achieved sequential quarter-over-quarter growth in dispensed units for Wycanth, the commercial asset for molluscum.
Wycanth has permanent J code, NC designation, and Orange Book listing.
Partnership with Torii Pharmaceutical in Japan includes milestone payments and global Phase III program for common warts.
Product pipeline and clinical data
Wycanth is FDA-approved for molluscum contagiosum in patients aged two and up, with strong clinical data showing rapid and significant lesion clearance.
Adverse events are mostly mild to moderate local skin reactions; no serious events reported.
Phase II program for common warts showed 51% complete resolution and robust persistence; global Phase III to start by year-end.
VP315 for basal cell carcinoma completed Phase II, showing 51% complete histological clearance and 86% tumor size reduction.
No treatment-related adverse events in VP315 Phase II; dual mechanism of action supports further development.
Commercial strategy and market access
Expanded access for Wycanth to pediatricians, dermatologists, and primary care, with dual buy-and-bill and specialty pharmacy options.
Robust Medicaid and commercial insurance coverage, with $25 copay assistance for up to two applicators.
Endorsement by AAP Red Book in 2024 highlights Wycanth's active ingredient as a preferred treatment.
Incremental revenue opportunity for clinicians via procedure codes; 225 million lives covered under insurance programs.
Specialty pharmacy delivery optimized for national and local access.
How has the dual benefit model boosted Wycanth?
Detail common warts royalty/milestone structure.
What VP315 Phase III design elements are critical for market adoption?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Verrica Pharmaceuticals earnings date
Q3 20253 Nov, 2025
Next Verrica Pharmaceuticals earnings date
Q3 20253 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Verrica Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for dermatological conditions, particularly those requiring medical interventions. The company is dedicated to addressing the unmet needs in medical dermatology by identifying, developing, and commercializing novel pharmaceutical products. Its pipeline includes product candidates aimed at treating a variety of skin diseases, leveraging research to offer new therapeutic options to patients and healthcare providers. The company is headquartered in West Chester, Pennsylvania, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage